Search

Your search keyword '"Gao, Yuanhong"' showing total 293 results
Start Over Author "Gao, Yuanhong"
293 results on '"Gao, Yuanhong"'

14. Nonvolatile Memory Organic Light‐Emitting Transistors

Author

Xu, Meili, primary, Zhao, Changbin, additional, Meng, Zhimin, additional, Yan, Hao, additional, Chen, Hongming, additional, Jiang, Zhixiang, additional, Jiang, Zhuonan, additional, Chen, Hong, additional, Meng, Lingqiang, additional, Hui, Wei, additional, Su, Zhenhuang, additional, Wang, Yueyue, additional, Wang, Zhenhui, additional, Wang, Jianing, additional, Gao, Yuanhong, additional, He, Yaowu, additional, and Meng, Hong, additional

Published
2023
Full Text
View/download PDF

19. Distinct clinical characteristics in stage III rectal cancer among different age groups and treatment outcomes after neoadjuvant chemoradiotherapy.

Author

Liu, Baoqiu, Luo, Huilong, Li, Bin, Yu, Haina, Sun, Rui, Li, Jibin, Gao, Yuanhong, Ding, Peirong, Wang, Xicheng, and Xiao, Weiwei

Abstract

Background: There is a rapidly increasing incidence of early-onset colorectal cancer (EO-CRC) which threatens the survival of young people, while aging also represents a challenging clinical problem. Objectives: We aimed to investigate the differences in the clinical characteristics and prognosis in stage III rectal cancer (RC), to help optimize treatment strategies. Design and methods: This study included 757 patients with stage III RC, all of whom received neoadjuvant chemoradiotherapy and total mesorectal excision. The whole cohort was categorized as very early onset (VEO, ⩽30 years old), early onset (EO, >30 years old, ⩽50 years old), intermediate onset (IO, >50 years, ⩽70 years), or late onset (LO, >70 years old). Results: There were more female VEO patients than males, more mucinous adenocarcinoma, signet-ring cell carcinoma, pre-treatment cT4 stage, and higher pre-treatment serum carbohydrate antigen 19-9 compared with the other three groups. VEO patients had the worst survival with the highest RC-related mortality (34.5%), recurrence (13.8%), and metastasis (51.7%). LO patients had the highest non-RC-related mortality rate (16.6%). The Cox regression model showed VEO was a negative independent prognostic factor for disease-free survival [DFS, hazard ratio (HR): 2.830, 95% confidence interval (CI): 1.633–4.904, p < 0.001], distant metastasis-free survival (DMFS, HR: 2.969, 95% CI: 1.720–5.127, p < 0.001), overall survival (OS, HR: 2.164, 95% CI: 1.102–4.249, p = 0.025), and cancer-specific survival (CSS, HR: 2.321, 95% CI: 1.145–4.705, p = 0.020). LO was a negative independent factor on DFS (HR: 1.800, 95% CI: 1.113–2.911, p = 0.017), DMFS (HR: 1.903, 95% CI: 1.150–3.149, p = 0.012), OS (HR: 2.856, 95% CI: 1.745–4.583, p < 0.001), and CSS (HR: 2.248, 95% CI: 1.282–3.942, p = 0.005). VEO patients had better survival in the total neoadjuvant therapy-like (TNT-like) pattern on DFS (p = 0.039). IO patients receiving TNT-like patterns had better survival on DFS, OS, and CSS (p = 0.006, p = 0.018, p = 0.006, respectively). Conclusion: In stage III RC, VEO patients exhibited unique clinicopathological characteristics, with VEO a negative independent prognostic factor for DFS, DMFS, OS, and CSS. VEO and IO patients may benefit from a TNT-like treatment pattern. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

22. Total neoadjuvant treatment to increase the clinical complete response rate for distal locally advanced rectal cancer ( TESS ): A study protocol of a prospective, open‐label, multicenter, single‐arm, phase 2 trial

Author

Liu, Shuang, primary, Wang, XiaoZhong, additional, Zhuang, YeZhong, additional, Bai, ShouMin, additional, Wu, XiaoJun, additional, Ye, YiJing, additional, Luo, HuiLong, additional, Yu, HaiNa, additional, Wang, QiaoXuan, additional, Chang, Hui, additional, Zeng, ZhiFan, additional, Cai, PeiQiang, additional, Pan, ZhiZhong, additional, Gao, YuanHong, additional, Chen, Gong, additional, and Xiao, WeiWei, additional

Published
2023
Full Text
View/download PDF

23. Supplementary Tables 1-4 from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

24. Supplementary Figure 2 from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

25. Supplementary Figure 5 from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

26. Supplementary Figure 3 from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

27. Data from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

28. Supplementary Figure 1 from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

29. Supplementary Table S1 from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

30. Supplementary Figure Legends from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

31. Supplementary Figure 6 from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

32. Supplementary Figure 4 from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

36. Short-Term Results of the SONCAR Study: Optimized Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients - A Prospective Randomized Controlled Phase III Study

Author

Zhang, Rongxin, primary, Wang, Fu-long, additional, Jiang, Xinhua, additional, Wang, Hao, additional, Zeng, Zhifan, additional, Gao, Yuanhong, additional, Wu, Xiaojun, additional, Chen, Gong, additional, Li, L.R., additional, Ding, Peirong, additional, Lu, Shixun, additional, Zhang, Jian, additional, Liu, Min, additional, Wang, Qiao-Xuan, additional, Xiao, Weiwei, additional, Pan, Zhizhong, additional, Wan, Desen, additional, and Lu, Zhenhai, additional

Published
2023
Full Text
View/download PDF

38. Efficient hole extraction and dark current suppression in organic photodetectors enabled by atomic-layer-deposition of ultrathin Co3O4 interlayers.

Author

Lu, Ke, Gao, Yuanhong, Wang, Zhenhui, Wang, Xinwei, and Meng, Hong

Abstract

Transition-metal oxides are widely used to improve the power conversion efficiencies of organic or perovskite solar cells because their chemical and electronic properties can be tuned to enable charge exchange with a wide variety of semiconductor materials. In this work, the atomic-layer-deposition of ultrathin Co3O4 anode interlayers which are used as hole transporting/electron blocking layers in organic photodetectors is investigated. Incident light loss and carrier transport loss could be minimized due to the ultrashort transport path. It is found that the highly smooth Co3O4 interlayer with a deep valence band of 5.3 eV and a shallow conduction band of 1.6 eV effectively promotes photogenerated charge extraction and suppresses the electron injection under reverse bias, resulting in a significantly improved photodetection performance. At an optimal Co3O4 thickness of 1 nm, the dark current of the Co3O4 device is almost 1 order of magnitude lower than that of the PEDOT:PSS device. As a result, we have demonstrated a P3HT:PC61BM-based device with a low dark current of 2.5 nA cm−2 and a high detectivity of 1013 Jones at −1 V bias, which are higher than those of the commercial silicon-based photodiodes. Such ultrathin charge blocking layers are proved to be versatile in reducing the dark current for devices with NIR-absorbing NFA. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

45. Nomogram to Predict Distant Metastasis Probability for Pathological Complete Response Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy [Corrigendum]

Author

Jiang, Ting, primary, Liu, Shuang, additional, Wu, Xiaojun, additional, Liu, Xiaoqing, additional, Li, Weizhan, additional, Yang, Shanfei, additional, Cai, Peiqiang, additional, Xi, Shaoyan, additional, Zeng, Zhifan, additional, Gao, Yuanhong, additional, Chen, Gong, additional, and Xiao, Weiwei, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results